407 results
Page 5 of 21
6-K
EX-99.1
kpn8y w0n5e
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
EX-99.1
bk9w9einvd 657
2 Mar 15
Teva Announces Sale of Sellersville, PA Facility
12:00am
6-K
EX-99.1
ign0rbt
27 Feb 15
Live Filing
12:00am
6-K
EX-99.1
1i1mqdit
25 Feb 15
Live Filing
12:00am
6-K
EX-99.1
4w3 d0ydl
24 Feb 15
TEVA ANNOUNCES POSITIVE RESULTS FOR TEV-48125 IN PHASE IIb CHRONIC MIGRAINE STUDY MEETING PRIMARY AND SECONDARY ENDPOINTS
12:00am
6-K
EX-99.1
tjmfc6w7bx62m
23 Feb 15
Live Filing
12:00am
6-K
EX-99.1
6h9dm6v
20 Feb 15
Teva to Present New Respiratory Data at 2015 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
12:00am
6-K
EX-99.1
cqio1 md4hty0
5 Feb 15
Live Filing
12:00am
6-K
EX-99.1
kym06x
5 Feb 15
Teva Reports Fourth Quarter and Full Year 2014 Results
12:00am
6-K
EX-99.1
8dy05vw6i50sm
26 Jan 15
Teva Receives Fda Approval for First Generic Nexium® Delayed-release Capsules In the United States
12:00am
6-K
EX-99.1
7l5a15i jrd9ux
20 Jan 15
Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE®20 mg/mL Case and Remand for Further Review
12:00am
6-K
EX-99.1
vztn6e4z98
7 Jan 15
Teva Launches Generic Diovan® In the United States
12:00am
6-K
EX-99.1
43dozcco3x0ujknl
23 Dec 14
Live Filing
12:00am
6-K
EX-99.1
eysna7h hgiah
19 Dec 14
First Waterless Nasal Allergy Spray Approved for Children as Young as Four Years of Age
12:00am
6-K
EX-99.1
vemr3
11 Dec 14
Teva Announces Launch of First Generic Celebrex® Capsules In the United States
12:00am
6-K
EX-99.1
dy4ji0lxvzrr4d2ktrl
11 Dec 14
Teva Provides 2015 Business Outlook
12:00am
6-K
EX-99.1
ae1jt3
4 Dec 14
Live Filing
12:00am
6-K
EX-99.1
n233 u9l5w17pe5r4a
1 Dec 14
Teva Announces Launch of Generic Exforge HCT® Tablets In the United States
12:00am